Trulicity patent expiry 2027?

Short answer: there isn’t a single “Trulicity patent expiry 2027” date. Trulicity (dulaglutide) is protected by a bundle of multiple patents and regulatory exclusivities, and the expiration dates vary by country and patent family. In the U.S., even after patent expiry, the Biologics Price Competition and Innovation Act provides 12 years of data exclusivity for a biologic like dulaglutide, which can push generic/biosimilar entry into the 2026–2027 time frame. In the EU and other regions, there are different data/market exclusivity rules that can also affect timing, often around 2025–2027 depending on when approvals were granted and patent coverage.

If you’d like, tell me your country or region and I can pull together the current, cited expiry dates for the relevant patent families and exclusivities from public sources (USPTO/Orange Book, EPO, Google Patents, etc.). Also, note that patent status can change due to litigation, settlements, or new patent filings.